Sanonash Pharma

Sanonash Pharma was a private Israeli biotech company associated with the name "SanoNash" and apparently focused on therapeutic approaches for nonalcoholic steatohepatitis and related metabolic disease. Publicly accessible corporate registry data indicate the legal entity was incorporated in Tel Aviv in 2017 as SANONASH PHARMA LTD. Evidence from third-party registry sources indicates the company was later voluntarily dissolved, and there is little public information suggesting an active operating business, clinical pipeline, or commercial products. Limited public references link SanoNash to life science entrepreneur Dr. Ronnie Hershman. The sparse public footprint suggests the company remained at an early, likely preclinical stage.